Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-86,300
Closed -$447K 4969
2026
Q1
$447K Buy
+86,300
New +$540K ﹤0.01% 3906
2025
Q2
Sell
-54,743
Closed -$352K 4441
2025
Q1
$352K Sell
54,743
-62,971
-53% -$560K ﹤0.01% 3684
2024
Q4
$1.12M Sell
117,714
-72,000
-38% -$632K ﹤0.01% 3138
2024
Q3
$1.55M Buy
189,714
+86,857
+84% +$902K ﹤0.01% 2911
2024
Q2
$1.39M Buy
+102,857
New +$860K ﹤0.01% 2957
2024
Q1
Sell
-225,371
Closed -$2.47M 4430
2023
Q4
$2.47M Sell
225,371
-12,572
-5% -$123K ﹤0.01% 2509
2023
Q3
$2.61M Buy
+237,943
New +$3.4M ﹤0.01% 2367

Other funds holding ENVX

David Shaw's ENVX Position: Q2 2026 in Review

David Shaw increased its Enovix (ENVX) stake by 7,568% in Q2 2026, buying an estimated $6.25M and bringing the position to 955,198 shares worth $5.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

David Shaw first reported a position in ENVX in Q1 2021 and has held it in 13 quarters since. The position peaked at $10.2M in Q3 2025. 297 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • David Shaw held 955,198 shares of Enovix worth $5.8M as of Q2 2026.
  • David Shaw bought 942,741 Enovix shares in Q2 2026, an estimated $6.25M.
  • Enovix made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2277 holding.
  • David Shaw first reported a position in Enovix in Q1 2021 and has held it in 13 quarters since.
  • David Shaw's Enovix position peaked at $10.2M in Q3 2025.
  • 297 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.